 |
|
|
 |
|
|
|
|
 |
|
|
 |
 |
|
|
 |
|
Theresa A.
Shapiro, MD, PhD
Division
Director
Wellcome Professor, Medicine, and Pharmacology
and Molecular Sciences |
|
Research
Interests:
Molecular and clinical pharmacology
of antiparasitic drugs; DNA topoisomerases
as antiparasitic drug targets; structure-activity
of synthetic antimalarial trioxanes
|
|
|
|
|
 |
|
Ying J. Cao, MD, Ph.D.
Assistant Professor- Medicine, and Pharmacology and Molecular Sciences
|
|
Research
Interests:
Pharmacokinetic and pharmacodynamic modeling of drug action at cellular, tissue, and population level; chemoprevention of HIV transmission; pharmacology of the male genital tract; clinical development of antiviral drugs
|
|
|
 |
 |
|
Albena Dinkova-Kostova, PhD
Assistant Professor, Medicine, and Pharmacology and Molecular Sciences |
|
Research
Interests:
Protection against cancer – mechanisms and strategies; structure-activity relation of protective agents; inflammation and cancer; skin cancer prevention
|
|
|
|
 |
|
Charles
Flexner, MD
Professor, Medicine, and Pharmacology and
Molecular Sciences, and International Health
(Bloomberg School of Public Health) |
|
Research
Interests:
HIV biology and antiretroviral
therapy; basic and clinical pharmacology of
HIV protease inhibitors
|
|
|
|
 |
|
Craig
Hendrix, MD
Director,
Drug Development Unit
Associate
Professor, Medicine (Clinical Pharmacology,
Infectious Diseases) and Pharmacology and
Molecular Sciences, and Epidemiology (Bloomberg
School of Public Health) |
|
Research
Interests:
Chemoprevention of HIV infection;
topical HIV microbicides; clinical pharmacology
of antiviral drugs; drug interactions
|
|
|
|
 |
|
Walter C. Hubbard, Ph. D.
Director, Mass Spectrometry Laboratory
Associate Professor, Medicine (Clinical Pharmacology and Allergy and Clinical Immunology-secondary) |
|
Research
Interests:
Quantitative mass spectrometry via combined liquid chromatography-tandem mass spectrometry and applications to clinical and laboratory research; (1) pharmacokinetics and metabolism of agents employed for treatment of HIV/AIDS and other viral disease; (2) lipid molecular species: potential for newborn screening for leukodystrophies and roles as mediators of signal transduction in cells.
|
|
|
|
 |
|
Paul
Lietman, MD, PhD
Professor,
Medicine, and Pediatrics, and Pharmacology
and Molecular Sciences |
|
Research
Interests:
International clinical research,
development of complementary and alternative
medicines, ethics of human experimentation,
and clinical pharmacology of antiviral drugs
|
|
|
|
|
 |
|
Brent
Petty, MD
Hospital
Pharmacologist
Associate
Professor, Medicine, and Pharmacology and
Molecular Sciences |
|
Research
Interests:
Phase I clinical trials;
comparative clinical trials of antimicrobials;
new treatments for peripheral neuropathy;
treatments for macular degeneration; medical
consultation and preoperative testing
|
|
|
|
 |
|
Rahul P. Bakshi, PhD
Research Associate, Medicine |
|
Interests:
Basic biology of parasitic protozoa, DNA topoisomerases as drug targets, pharmacokinetic-pharmacodynamic relationships of drugs, preclinical development of anti-infective agents
|
|
|
|
 |
|
Edward J. Fuchs, PA-C, MBA
Associate Clinical Director, Drug Development Unit
Research Associate, Medicine |
|
Interests:
Topical HIV microbicides, application of imaging technologies in clinical pharmacology, empirical assessment of clinical research ethics.
|
|
|
|
 |
|
Teresa L. Parsons, PhD
Research Associate, Medicine |
|
Research
Interests:
Quantitative analysis of drugs and metabolites in clinical samples.
|
|
|
|
 |
|
Laura
Rocco, RN, MS
Research
Associate, Medicine |
|
Research
Interests:
Informed consent for clinical research;
institutional and investigator compliance
with research regulations
|
|
|
|
 |
|
Jane
Scocca, PhD
Research
Associate, Medicine |
|
Research
Interests:
Understanding the mechanisms
of drug cytotoxicity in trypanosomes and malaria
parasites and identification of potential
drug targets in these organisms; and many
aspects of glycobiology and particularly the
structure, synthesis and function of the carbohydrate
moieties of glycoproteins.
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
